Publications in collaboration with researchers from Holy Name Medical Center (2)

2020

  1. Exploratory evaluation of bezlotoxumab on outcomes associated with clostridioides difficile infection in MODIFY I/II Participants with Cancer

    Open Forum Infectious Diseases, Vol. 7, Núm. 2

2017

  1. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    New England Journal of Medicine, Vol. 376, Núm. 4, pp. 305-317